Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia therapy for cancer treatment; and nanomedical therapy for the treatment of colorectal cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; bovine TB tests; and concussion screening tests. Sona Nanotech Inc. was founded in 2013 and is based in Halifax, Canada.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Regan, David

Employees

Website

www.sonanano.com

IPO Date

2006-07-14

Headquarters

Purdy’s Wharf Tower II, Suite 2001, 1969 Upper Water Street, Halifax, Nova Scotia, B3J 3R7, Canada

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Sona Nanotech SONA

Sona Nanotech Earnings Call Summary

Sona Nanotech Earnings

Transcripts

Events

About Sona Nanotech Inc.

Sona Nanotech
SONA